首页> 外文期刊>Breast care >Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery
【24h】

Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery

机译:乳房的Desmoid型纤维瘤:成像,组织病理学和手术的十年制度结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Desmoid type fibromatoses has proven to be a diagnostic and therapeutic challenge, as they often appear primarily as a carcinoma of the breast with a high recurrence risk. Patients: A digital archive search was performed for the period from 2009 to the end of 2018. Inclusion criteria consisted of histological examination of at least the surgical specimen in the reference pathology department and at least a second opinion diagnosis in the reference radiology department. Results: A total of 14 women and 1 man underwent surgery on desmoid type fibromatosisof the breast. The average patient age was 49 years (range: 22-72 years). The mean tumor size was 2.2 cm (range: 0.8-4.2 cm). The tumor was detectable in mammography in 12 out of 13 patients and in all 15 patients in sonography. MRI was performed preoperatively in 6 patients; in all of the patients, the tumor was visualized with inhomogeneous contrast enhancement. In the imaging procedures, all desmoid type fibromatoses were classified as suspicious. Performing the core biopsy, preoperative histology confirmed desmoid fibromatosis in 12 out of 15 patients. Nuclear stain for ss-catenin was positive in 7 out of 10 patients.Negative staining was found for AE1/A3 in 10 out of 10 and CD34 in 12 out of 12 patients. In all of the patients, a single-stage operation without the detection of border-forming tumor margins was performed. The follow-up interval ranged from 16 to 96 months (mean: 44.86 months, median: 43 months). In this follow-up period, no patient was diagnosed with desmoid tumor recurrence. Conclusion: In imaging, desmoid type fibromatosis of the breast has typical malignancy-related criteria. Extensive preoperative diagnostics enable the planning of complete primary excision of the lesion and reduce the recurrence risk.
机译:背景:DESMOID型纤维瘤已被证明是一种诊断和治疗挑战,因为它们通常主要作为乳腺癌的癌,具有高的复发风险。患者:在2009年至2018年底之前进行了数字档案搜索。纳入标准由参考病理署中至少有手术标本的组织学检查组成,至少是参考放射学部门的第二种意见诊断。结果:共14名妇女和1名男子接受乳腺纤维瘤纤维瘤的手术。平均患者年龄为49岁(范围:22-72岁)。平均肿瘤大小为2.2厘米(范围:0.8-4.2厘米)。肿瘤在13名患者中的12例中有12例,并且在所有15名儿科患者中可检测到乳腺X线摄影中。 MRI在6名患者中术前进行;在所有患者中,肿瘤都被视为不均匀的造影增强。在成像程序中,所有DES系列纤维瘤被归类为可疑。进行核心活组织检查,术前组织学证实了15名患者中12例中的120例纤维瘤。 SS-Catenin的核染色剂在10名患者中的7例中有7例。在12名患者中10例中的10个和CD34中的10分中,发现了Negatived染色。在所有患者中,在没有检测到形成边界形成肿瘤边缘的单级操作。后续间隔从16到96个月范围(平均:44.86个月,中位数:43个月)。在这种后续期间,没有患者诊断患有Demoroid肿瘤复发。结论:在成像中,乳房的Demopoid型纤维瘤有关的恶性肿瘤相关标准。广泛的术前诊断能够规划损伤的完整初级切除并降低复发风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号